Patent · US Active

Cyclin based inhibitors of CDK2 and CDK4

US9982015B2 · kind B2 · utility

3Cited by
4References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2016
Grant dateMay 29, 2018
Priority date
Expiry dateJun 24, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Structural and functional analysis of peptide inhibitor binding to the cyclin D and cyclin A groove has been investigated and used to design peptides that provide the basis for structure-activity relationships, have improved binding and have potential for development as chemical biology probes, as potential diagnostics and as therapeutics in the treatment of proliferative diseases including cancer and inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.